The legacy success of sildenafil has undeniably influenced the drug landscape. However, investing in companies heavily focused on biosimilars and the diminishing patent exclusivity surrounding this https://minanfhv388237.designertoblog.com/72390977/the-blue-pill-and-drugmakers-a-risky-investment